Pills to wellness, Cipla is seeking a new identity
Drugmaker Cipla wants to be more than just a pharmaceutical company selling a pill and aims to play a bigger role in a patient’s journey from illness to wellness.
Samina Hamied, executive vice-chairperson who won the ET Businesswoman of the Year 2021, in an interview with ET said that in the post-Covid world, Cipla wants to handhold patients right from testing, treatment adherence, building awareness, wellness and accessibility to medicines.
In addition, Hamied said the 86-year old company is trying to ascend the value chain by investing higher capital in biologics, and it is exploring new frontiers of science such as messenger RNA, and CAR T-cell (anti-cancer), and gene therapies. The company has also invested in a stem cell therapy. Hamied added that all the new forays would be through collaborations and partnerships.